Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Influenza

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Diphtheria outbreak, Northern Territory of Australia, 2025 to 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

Same author

Streamlining the Histopathologic Workflow in Diabetic Kidney Disease with Artificial Intelligence.

Journal of the American Society of Nephrology : JASN·2025

Same author

Invasive Streptococcus dysgalactiae subspecies equisimilis compared with Streptococcus pyogenes in Australia, 2011-23, and the emergence of a multi-continent stG62647 lineage: a retrospective clinical and genomic epidemiology study.

The Lancet. Microbe·2025

Same author

Drivers and mechanisms of cognitive decline in chronic kidney disease.

Nature reviews. Nephrology·2025

Same author

Temporal and geographical lineage dynamics of invasive Streptococcus pyogenes in Australia from 2011 to 2023: a retrospective, multicentre, clinical and genomic epidemiology study.

The Lancet. Microbe·2025

Same author

A Serological Assay for the Detection of Antibodies Generated Against California Serogroup Virus Infection.

Methods in molecular biology (Clifton, N.J.)·2024

Search research articles

Related Experiment Video

Updated: May 16, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Invasive pneumococcal disease in Australia 2007 and 2008.

Christina Barry¹, Vicki L Krause, Heather M Cook

¹Vaccine Preventable Diseases Surveillance Section, Office of Health Protection, Department of Health and Ageing, Canberra, Australian Capital Territory 2601. Christina.Barry@health.gov.au

Communicable Diseases Intelligence Quarterly Report

|November 29, 2012

Summary

This summary is machine-generated.

Invasive pneumococcal disease (IPD) surveillance in Australia shows declining vaccine-type IPD rates in non-Indigenous children due to the 7-valent pneumococcal conjugate vaccine (7vPCV) program. However, non-vaccine serotype IPD, particularly serotype 19A, has increased significantly.

More Related Videos

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

Related Experiment Videos

Last Updated: May 16, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

Area of Science:

Epidemiology
Infectious Diseases
Vaccinology

Background:

Invasive pneumococcal disease (IPD) surveillance is crucial for monitoring disease trends and vaccine effectiveness.
Australia has conducted enhanced IPD surveillance since 2002, with comprehensive data available for 2007-2008.
Indigenous Australians experience disproportionately higher rates of IPD compared to non-Indigenous Australians.

Purpose of the Study:

To analyze trends in IPD notification rates and serotype distribution in Australia from 2002 to 2008.
To evaluate the impact of the 7-valent pneumococcal conjugate vaccine (7vPCV) program on IPD rates in different age groups and populations.
To assess changes in antibiotic susceptibility of invasive pneumococcal isolates.

Main Methods:

Retrospective analysis of IPD case notifications to the National Notifiable Diseases Surveillance System (NNDSS) in Australia.
Comparison of IPD rates and serotype distribution between 2002 and 2007-2008.
Analysis of vaccine serotype and non-vaccine serotype IPD rates in Indigenous and non-Indigenous populations, stratified by age.

Main Results:

Overall IPD notification rates were 7.0 per 100,000 in 2007 and 7.6 per 100,000 in 2008.
IPD rates in Indigenous Australians were almost 5-6 times higher than in non-Indigenous Australians.
Vaccine serotype IPD rates in non-Indigenous children under 5 decreased by 96% by 2008, while non-vaccine serotype IPD, including serotype 19A, increased by 168%.

Conclusions:

The 7vPCV program has been highly effective in reducing vaccine-type IPD in non-Indigenous children.
There is a concerning increase in IPD caused by non-vaccine serotypes, particularly serotype 19A, in young children.
IPD remains a significant public health issue for Indigenous Australians, with increasing rates of disease due to 23-valent pneumococcal polysaccharide vaccine (23vPPV) serotypes in adults.